C. Mathers and D. Loncar, Projections of Global Mortality and Burden of Disease from 2002 to 2030, PLoS Medicine, vol.52, issue.11, p.442, 2002.
DOI : 10.1371/journal.pmed.0030442.st007

J. Soriano, J. Zielinski, and D. Price, Screening for and early detection of chronic obstructive pulmonary disease, The Lancet, vol.374, issue.9691, pp.721-753, 2009.
DOI : 10.1016/S0140-6736(09)61290-3

D. Coultas, D. Mapel, R. Gagnon, and E. Lydick, The Health Impact of Undiagnosed Airflow Obstruction in a National Sample of United States Adults, American Journal of Respiratory and Critical Care Medicine, vol.164, issue.3, pp.372-379, 2001.
DOI : 10.1164/ajrccm.164.3.2004029

J. Hurst, J. Vestbo, A. Anzueto, N. Locantore, H. Mullerova et al., Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.363, issue.12, pp.1128-1166, 2010.
DOI : 10.1056/NEJMoa0909883

D. Price, A. Crockett, M. Arne, B. Garbe, R. Jones et al., Spirometry in primary care case-identification, diagnosis and management of COPD, Primary Care Respiratory Journal, vol.18, issue.3, pp.216-239, 2009.
DOI : 10.4104/pcrj.2009.00055

S. Nelson, L. Lavange, Y. Nie, J. Walsh, P. Enright et al., Questionnaires and Pocket Spirometers Provide an Alternative Approach for COPD Screening in the General Population, Chest, vol.142, issue.2, pp.358-66, 2012.
DOI : 10.1378/chest.11-1474

P. Silkoff, A. Stevens, J. Pak, B. Bucher-bartelson, and R. Martin, A Method for the Standardized Offline Collection of Exhaled Nitric Oxide, Chest, vol.116, issue.3, pp.754-763, 1999.
DOI : 10.1378/chest.116.3.754

J. Guerin, N. Roche, E. Vicaut, D. Piperno, G. Granet et al., Sujets ?? risque de BPCO en m??decine g??n??rale??: comment favoriser la r??alisation de spirom??tries et la d??tection pr??coce de l???obstruction bronchique???, Revue des Maladies Respiratoires, vol.29, issue.7, pp.889-97, 2012.
DOI : 10.1016/j.rmr.2012.03.005

K. Chibana, Y. Ishii, Y. Anraku, and T. Fukuda, Prevalence of Airflow Limitation in Patients Diagnosed and Treated for Symptoms of Chronic Bronchitis by General Practitioners in Tochigi Prefecture, Japan, Internal Medicine, vol.50, issue.20, pp.2277-83, 2011.
DOI : 10.2169/internalmedicine.50.5115

P. Frith, A. Crockett, J. Beilby, D. Marshall, R. Attewell et al., Simplified COPD screening: validation of the PiKo-6?? in primary care, Primary Care Respiratory Journal, vol.8, issue.5, pp.190-198, 2011.
DOI : 10.1016/S0002-9343(03)00185-2

L. Sichletidis, D. Spyratos, M. Papaioannou, D. Chloros, A. Tsiotsios et al., A combination of the IPAG questionnaire and PiKo-6?? flow meter is a valuable screening tool for COPD in the primary care setting, Primary Care Respiratory Journal, vol.2, issue.6, pp.184-193, 2011.
DOI : 10.1177/1059601101262003

P. Solidoro, F. Braido, F. Baratta, D. Bagnasco, R. Esposito et al., FEV6 assessment in spirometric abnormalities screening: the first populationbased study in Italian pharmacies, Panminerva Med, vol.55, issue.1, pp.87-92, 2013.

N. Gross, Chronic Obstructive Pulmonary Disease Outcome Measurements: What's Important? What's Useful?, Proceedings of the American Thoracic Society, vol.2, issue.4, pp.267-71, 2005.
DOI : 10.1513/pats.200504-036SR
URL : http://doi.org/10.1513/pats.200504-036sr

O. Pedersen, FEV6: a shortcut in spirometry?, European Respiratory Journal, vol.27, issue.2, pp.245-252, 2006.
DOI : 10.1183/09031936.06.00134405

J. Vandevoorde, S. Verbanck, D. Schuermans, J. Kartounian, and W. Vincken, FEV1/FEV6 and FEV6 as an Alternative for FEV1/FVC and FVC in the Spirometric Detection of Airway Obstruction and Restriction, Chest, vol.127, issue.5, pp.1560-1564, 2005.
DOI : 10.1378/chest.127.5.1560

D. Castillo, R. Guayta, J. Giner, F. Burgos, C. Capdevila et al., COPD case finding by spirometry in high-risk customers of urban community pharmacies: A pilot study, Respiratory Medicine, vol.103, issue.6, pp.839-884, 2009.
DOI : 10.1016/j.rmed.2008.12.022

M. Takemura, K. Mitsui, M. Ido, M. Matsumoto, M. Koyama et al., Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients, International Journal of Chronic Obstructive Pulmonary Disease, vol.8, pp.239-283, 2013.
DOI : 10.2147/COPD.S44022

A. Verma, A. Harrison, P. Torun, J. Vestbo, R. Edwards et al., Are pharmacists reducing COPD???S impact through smoking cessation and assessing inhaled steroid use?, Respiratory Medicine, vol.106, issue.2, pp.230-234, 2012.
DOI : 10.1016/j.rmed.2011.08.011
URL : http://doi.org/10.1016/j.rmed.2011.08.011

J. Kanne, Screening for Lung Cancer: What Have We Learned?, American Journal of Roentgenology, vol.202, issue.3, pp.530-535, 2014.
DOI : 10.2214/AJR.13.11540

D. Aberle, S. Demello, C. Berg, W. Black, B. Brewer et al., Results of the Two Incidence Screenings in the National Lung Screening Trial, New England Journal of Medicine, vol.369, issue.10, pp.920-951, 2013.
DOI : 10.1056/NEJMoa1208962

J. Zurawska, J. R. Lam, S. Coxson, H. Leipsic, J. Sin et al., What to Do When a Smoker's CT Scan Is ???Normal????, Chest, vol.141, issue.5, pp.1147-52, 2012.
DOI : 10.1378/chest.11-1863

J. Cordier, V. Cottin, C. Khouatra, and D. Revel, Screening for Lung Cancer and Idiopathic Pulmonary Fibrosis: Killing Two Birds with One Stone, Radiology, vol.270, issue.2, pp.630-631, 2014.
DOI : 10.1148/radiol.13131866